In a remarkable initiative supported by Yamanashi Prefecture, Kokoromil Inc. has unveiled the successful results of a pioneering study aimed at early detection of heart disease and sleep apnea among its residents. Utilizing the wearable ECG system "Home Heart Dock Pro," this project involved collaboration with two local companies and tested 94 individuals, demonstrating a significant detection rate of 31% for arrhythmias and 36% for signs of sleep apnea.
Background of the Experiment
Heart disease ranks as the leading health issue in Yamanashi Prefecture, particularly among the aging population who often face a lack of convenient access to healthcare. Traditional ECG tests during routine health check-ups are limited to roughly 15 seconds, insufficient for identifying transient arrhythmias or hidden risks. Recognizing the challenges that busy professionals encounter—such as limited time for medical appointments and the misconception that symptoms aren’t serious—the study introduced a comprehensive 24-hour screening system that participants could use in the comfort of their homes or workplaces.
Results and Achievements
The screening demonstrated an exceptional effectiveness rate, resulting in the identification of potential health risks that traditional methods may overlook. While typical health check-ups indicate an arrhythmia detection rate around 10%, this project uncovered a rate of approximately 31%. Additionally, concerning signs of sleep apnea were detected at a rate of 36%. Among the individuals flagged for further assessment, four out of five utilized telehealth services and seamlessly transitioned into specialized care at Yamanashi Prefectural Central Hospital, achieving a 100% connection rate for recommended follow-up care.
Dr. Umetani, head of the Cardiology Department at Yamanashi Prefectural Central Hospital, commented on the significance of early-arrhythmia detection, highlighting that many patients with atrial fibrillation often show no symptoms leading to critical medical events like stroke or heart failure. The integration of 24-hour ECG monitoring as part of routine health checks is a game changer in preventive healthcare, potentially saving lives through timely intervention.
Future Prospects
Building on this success in Yamanashi, Kokoromil aims to expand this model across the country. The goal is to create a robust framework of regional medical cooperation that incorporates digital health technologies, ensuring that every individual can easily access necessary healthcare services.
About Home Heart Dock Pro
The Home Heart Dock Pro makes long-term ECG monitoring accessible, allowing users to attach a small device to their chest that records data for over nine hours. This comprehensive examination is analyzed by certified clinical technicians who provide a detailed report of findings.
Patients also benefit from integrated care options such as online consultations, enabling them to discuss results and obtain referrals to specialists without the logistical challenge of in-person visits. With its convenient design, the Home Heart Dock Pro is garnering positive feedback from middle-aged individuals juggling busy lives, as well as from seniors or those in remote areas with limited access to healthcare facilities.
Kokoromil is committed to creating a preventative health society where individuals can monitor their cardiovascular health effortlessly and with peace of mind. Their mission forms part of a larger vision to eliminate sudden death from health complications, ultimately aiming to save lives through improved access to health insights.
For more information about the Home Heart Dock Pro, visit
their official product page.
About Kokoromil
Founded in 2021 and headquartered in Shinjuku, Tokyo, Kokoromil’s mission is "To create a society free from health-related regrets" by developing flexible healthcare solutions. They provide services designed to visualize heart rhythm disorders, sleep apnea symptoms, and other stress indicators, enhancing the overall healthcare experience for users while promoting quality of life and longevity.
Company Info:
CEO: Daiki Hayashi
Address: 6-2-16 Nishi-Shinjuku, Shinjuku, Tokyo 160-0023, Japan
Established: November 2021
Services: Healthcare and clinical research, focusing on home-based ECG monitoring and preventive health care solutions.